Huang LH, Tung MC, Weng WC, Hsu CY, et al. Neoadjuvant Nivolumab-Ipilimumab versus Platinum-Based Chemotherapy in Muscle-Invasive Bladder Cancer: A Single-Institution, Propensity-Weighted Cohort Study. Cancer Manag Res 2026;18:642002.
PMID: 42992115